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Abstract 
Clinical and patient-reported outcomes have been reported for carious primary molars treated 
using the Hall Technique (HT) compared with conventional carious tissue removal and 
restorations (CR) in a 5-year randomized-controlled practice-based trial in Scotland. We have 
further interrogated this dataset to investigate the cost-effectiveness of HT versus CR. 132 
children had two matched occlusal/occlusal-proximal carious lesions in primary molars (n=264 
teeth) were randomly allocated to HT or CR, provided by 17 general dental practitioners. 
Molars were followed up for a mean of five years. A societal perspective was taken for the 
economic analysis. Direct dental treatment costs were estimated from a Scottish NHS 
perspective (an NHS England perspective was taken for a sensitivity analysis). Initial, 
maintenance and re-treatment costs, including re-restorations, endodontic treatments and 
extractions, were estimated using fee items. Indirect/opportunity costs were estimated using 
time and travel costs from a UK perspective. The primary outcome was tooth survival. 
Secondary outcomes were not having pain or needing endodontic treatments/extractions, and 
not needing re-restorations. Cost-effectiveness and acceptability were estimated from 
bootstrapped samples. Significantly more molars in HT survived (99, 95% CI: 98-100%) than 
in CR (92; 87-97%). Also, the proportion of molars retained without pain or requiring endodontic 
treatment/extraction was significantly higher in HT than CR. In the base-case analysis (NHS 
Scotland perspective), cumulative direct dental treatment costs of the HT were 24 (23-25) 
GBP; costs for CR were 29 (17-46) GBP. In an NHS England perspective, the cost advantage 
of HT (29; 25-34 GBP) over CR (107; 86-127 GBP) was more pronounced. Indirect/opportunity 
costs were significantly lower for HT (32, 31-34 GBP) than CR (49; 34-69 GBP). Total 
cumulative costs were significantly lower for HT (32; 31-34 GBP) than CR (49; 34-69 GBP). 
Based on a long-term practice-based trial, HT was more cost-effective than CR.  
 
  
Introduction 
The expenditures (direct treatment costs) for managing dental diseases have been estimated 
at 356.80 billion USD globally, and productivity losses (indirect costs) due to dental diseases 
have been estimated at 187.61 billion USD { ADDIN EN.CITE 
<EndNote><Cite><Author>Righolt</Author><Year>2018</Year><RecNum>19665</RecNu
m><DisplayText>(Righolt et al. 2018)</DisplayText><record><rec-number>19665</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1521550958">19665</key></foreign-keys><ref-type name="Journal 
Article">17</ref-type><contributors><authors><author>Righolt, A. 
J.</author><author>Jevdjevic, M.</author><author>Marcenes, W.</author><author>Listl, 
S.</author></authors></contributors><auth-address>1 Department of Quality and Safety of 
Oral Healthcare, Radboud University, Radboud UMC, Nijmegen, the Netherlands.&#xD;2 
Division of Population and Patient Health, King&apos;s College London Dental Institute, 
London, UK.&#xD;3 Department of Conservative Dentistry, Translational Health Economics 
Group, Heidelberg University, Heidelberg, Germany.</auth-address><titles><title>Global-, 
Regional-, and Country-Level Economic Impacts of Dental Diseases in 
2015</title><secondary-title>J Dent Res</secondary-title><alt-title>Journal of dental 
research</alt-title></titles><periodical><full-title>J Dent Res</full-title><abbr-1>Journal of 
dental research</abbr-1></periodical><alt-periodical><full-title>J Dent Res</full-title><abbr-
1>Journal of dental research</abbr-1></alt-
periodical><pages>22034517750572</pages><edition>2018/01/18</edition><keywords><k
eyword>dental public health</keyword><keyword>epidemiology</keyword><keyword>health 
services research</keyword><keyword>oral health</keyword><keyword>productivity 
losses</keyword><keyword>treatment 
expenditures</keyword></keywords><dates><year>2018</year><pub-dates><date>Jan 
1</date></pub-dates></dates><isbn>0022-0345</isbn><accession-
num>29342371</accession-num><urls></urls><electronic-resource-
num>10.1177/0022034517750572</electronic-resource-num><remote-database-
provider>NLM</remote-database-
provider><language>eng</language></record></Cite></EndNote>}. A large share of these 
costs is generated from managing dental caries, the most prevalent condition of humankind { 
ADDIN EN.CITE { ADDIN EN.CITE.DATA }}. There is great need for effective and cost-
effective interventions for preventing and managing carious lesions.  
Partially as a result of increased preventive public health efforts, caries experience in Scottish 
children has declined over the last 15 years. However, in common with other countries, 
management of carious lesions continue to be a problem across the UK, the proportion of 
managed carious lesions in primary teeth remains low at only 15% in Scotland { ADDIN 
EN.CITE 
<EndNote><Cite><Author>NDIP</Author><Year>2016</Year><RecNum>19727</RecNum>
<DisplayText>(NDIP 2016)</DisplayText><record><rec-number>19727</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1525263513">19727</key></foreign-keys><ref-type name="Web 
Page">12</ref-
type><contributors><authors><author>NDIP</author></authors></contributors><titles><title
>Report of the 2016 Detailed National Dental Inspection Programme of Primary 1 children and 
the Basic Inspection of Primary 1 and Primary 7 
children</title></titles><dates><year>2016</year></dates><pub-
location>http://ndip.scottishdental.org/wp-content/uploads/2016/10/2016-10-25-NDIP-
Report.pdf </pub-location><urls></urls></record></Cite></EndNote>} and 14% in England { 
ADDIN EN.CITE 
<EndNote><Cite><Author>Davies</Author><Year>2012</Year><RecNum>19755</RecNum
><DisplayText>(Davies et al. 2012)</DisplayText><record><rec-number>19755</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1526198454">19755</key></foreign-keys><ref-type name="Web 
Page">12</ref-type><contributors><authors><author>Davies, G.</author><author>Neville, 
J.</author><author>Rooney, E.</author><author>Robinson, M.</author><author>Jones, 
A.</author><author>Perkins, C.</author></authors></contributors><titles><title>National 
Dental Epidemiology Programme for England: oral health survey of five-year-old-children 
2012</title></titles><dates><year>2012</year></dates><pub-
location>http://www.nwph.net/dentalhealth/Oral%20Health%205yr%20old%20children%2020
12%20final%20report%20gateway%20approved.pdf </pub-
location><urls></urls></record></Cite></EndNote>}. This might be because providing care for 
these primary teeth is seen as either not being required or, not feasible as they are in children. 
Indeed, there is evidence that restoration failure in primary teeth is common when conventional 
carious tissue removal and direct restorations (CR) are employed { ADDIN EN.CITE { ADDIN 
EN.CITE.DATA }}. The Hall Technique (HT) has been shown to be a clinically effective 
treatment option that is considered more acceptable to parents/carers, children and dentists { 
ADDIN EN.CITE { ADDIN EN.CITE.DATA }}.  
Cost-effectiveness considers initial treatment costs, but also costs for re-treatments such as 
re-restoration, endodontic treatments (pulp therapy) or extractions. Treatments which are 
initially more costly but also more effective may, eventually, be cost-effective long-term. A 
recent clinical study found HT more cost-effective than CR and non-restorative cavity control, 
over 2 years in a German setting (Schwendicke et al. 2018). The study reported here aimed 
to assess the cost-effectiveness of HT versus CR for managing cavitated carious lesions in 
primary molars over a longer period of time, building on data from a randomized controlled 5-
year practice-based trial in Scotland. 
 
 
 
Materials and Methods 
Reporting for this study follows the Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS) { ADDIN EN.CITE { ADDIN EN.CITE.DATA }}. The trial had been 
registered (ISRCTN 47267893) and ethically approved (Tayside Committee on Medical 
Research Ethics approval 108/00). Note that this economic evaluation had not been explicitly 
planned a priori and is an analysis of an existing dataset. The trial methodology is described 
in detail elsewhere { ADDIN EN.CITE 
<EndNote><Cite><Author>Innes</Author><Year>2007</Year><RecNum>345</RecNum><
DisplayText>(Innes et al. 2007)</DisplayText><record><rec-number>345</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="0">345</key></foreign-keys><ref-type name="Journal Article">17</ref-
type><contributors><authors><author>Innes, Nicola</author><author>Evans, 
Dafydd</author><author>Stirrups, 
David</author></authors></contributors><titles><title>The Hall Technique; a randomized 
controlled clinical trial of a novel method of managing carious primary molars in general dental 
practice: acceptability of the technique and outcomes at 23 months</title><secondary-
title>BMC Oral Health</secondary-title></titles><periodical><full-title>BMC Oral Health</full-
title><abbr-1>BMC oral health</abbr-
1></periodical><pages>18</pages><volume>7</volume><number>1</number><dates><ye
ar>2007</year></dates><isbn>1472-6831</isbn><accession-num>doi:10.1186/1472-6831-
7-18</accession-num><urls><related-urls><url>http://www.biomedcentral.com/1472-
6831/7/18</url></related-urls></urls></record></Cite></EndNote>} but given briefly here. 
 
Target population, setting and training 
Our analyses are based on a randomized controlled split-mouth trial in General Dental Practice 
in Scotland, UK, that aimed to compare HT versus CR (defined as General Dental 
Practitioners’ [GDPs] standard carious tissue removal and direct restorations). The target 
population were children with asymptomatic primary molars matched for tooth type, arch and 
lesion (for surface and extent), recruited between 2001 and 2004. 
All GDPs in Tayside, Scotland (n=143), were invited by mail to take part.  From the 41 replies  
expressing an interest (29% positive response rate), 17 GDPs were selected to obtain a spread 
of practices from rural, urban and mixed locations. The mean regional d3mft was 2.47 (d=1.71; 
m=0.54; f=0.22). Dentists were not required to sequentially screen and invite eligible children 
but were asked to recruit up to 10 children who met the following inclusion criteria: (1) 4 to 9 
years of age, with no medical complications (note that eventually, some dentists had recruited 
children aged 3 or 10 years, these were retained in the trial); (2) presenting for routine dental 
care with two unrestored primary molars with carious lesions into dentin that were matched for 
tooth type, dental arch, and extent of the lesion (radiographically ≤ or > ½ way through dentin), 
and were symptomless, with no clinical or radiographic signs indicating pulpal pathology on 
bitewing radiographs as assessed by the GDP. The number of recruited participants recruited 
per dentist varied from 0 to 21 (median 8). The GDPs attended a single, three hour training 
session at Dundee Dental Hospital and School, which consisted of: a presentation on the study 
background and aims; instruction by a dental radiographer in obtaining standardized bitewing 
radiographs, using Rinn dental film holders and size 0 bitewing radiographs; interpretation of 
bitewing radiographs led by a consultant dental radiologist; observation of the HT being carried 
out on one child by a consultant in Pediatric Dentistry; and discussion of pre-circulated 
paperwork, and a brainstorming session to anticipate and problem solve possible hurdles. No 
additional training was provided on carrying out CR, as the trial was pragmatic in design and 
testing HT versus CR as usual practice. The trial was eventually conducted with 132 children 
(264 primary molars), Subgroups of children’s gender, dental arch and molar were accounted 
for during analysis.  
 
Comparators and horizon 
There were 264 study molars with carious lesions; 67% were occluso-proximal; 42% had 
carious lesions extending radiographically over half-way into dentine. Teeth were randomized 
to either HT (intervention) or CR (control). HT was carried out by removing food debris, if there 
was any in the cavity, and placing a preformed metal crown over the primary molar, once the 
correct size was chosen, using glass ionomer cement. The crown was seated with finger 
pressure and the child instructed to bite down hard to fully seat the crown and keep pressure 
on the crown until the cement had set. Local anaesthesia was not used and no attempt was 
made to remove any of the carious lesion or prepare the molar. For CR, GDPs were asked to 
carry out their usual treatment and record whether they had removed all of the carious tooth 
tissue. Ninety-one patients (69%) had 4 years’ minimum follow-up; the mean follow-up period 
was 5 years. 
 
Sample size and randomization 
Sample size estimation had been based on a systematic review { ADDIN EN.CITE 
<EndNote><Cite><Author>Randall</Author><Year>2000</Year><RecNum>19730</RecNu
m><DisplayText>(Randall et al. 2000)</DisplayText><record><rec-number>19730</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1525267949">19730</key></foreign-keys><ref-type name="Journal 
Article">17</ref-type><contributors><authors><author>Randall, R. 
C.</author><author>Vrijhoef, M. M.</author><author>Wilson, N. 
H.</author></authors></contributors><auth-address>3M Dental, Laboratoires 3M Sante, 
Cergy Pontoise, France.</auth-address><titles><title>Efficacy of preformed metal crowns vs. 
amalgam restorations in primary molars: a systematic review</title><secondary-title>J Am 
Dent Assoc</secondary-title><alt-title>Journal of the American Dental Association (1939)</alt-
title></titles><periodical><full-title>J Am Dent Assoc</full-title><abbr-1>Journal of the 
American Dental Association (1939)</abbr-1></periodical><alt-periodical><full-title>J Am 
Dent Assoc</full-title><abbr-1>Journal of the American Dental Association (1939)</abbr-
1></alt-periodical><pages>337-
43</pages><volume>131</volume><number>3</number><edition>2000/03/15</edition><ke
ywords><keyword>*Crowns/statistics &amp; numerical data</keyword><keyword>*Dental 
Amalgam</keyword><keyword>Dental Restoration Failure</keyword><keyword>*Dental 
Restoration, Permanent/statistics &amp; numerical 
data</keyword><keyword>Humans</keyword><keyword>*Molar</keyword><keyword>Time 
Factors</keyword><keyword>Treatment 
Outcome</keyword></keywords><dates><year>2000</year><pub-
dates><date>Mar</date></pub-dates></dates><isbn>0002-8177 (Print)&#xD;0002-
8177</isbn><accession-num>10715925</accession-num><urls></urls><remote-database-
provider>NLM</remote-database-
provider><language>eng</language></record></Cite></EndNote>} where the mean hazard 
ratio (HR) was 0.32 in favor of conventionally placed preformed crowns  compared to amalgam 
restorations. Using a two-tailed test (= 0.05) and a power of 1-=80%, 58 participants were 
required to show a difference of 50% in the primary outcome, which was clinically and/or 
radiographically detected failure, at two years. Allowing for loss to follow-up, it was estimated 
that a minimum of 120 children should be recruited. Following consent, computer-generated 
centralized randomization was used (accessed by phone call) for treatment allocation (10th 
generation blocking).   
 
Horizon 
The horizon of the present analysis is the follow-up period of the trial; 5 years mean. This 
period allowed for the exfoliation of many teeth, which is the final survival event (primary teeth 
cannot survive for longer).  
 
Data  
The following data were recorded: 
 The time taken to explain each treatment; 
 The time taken to provide the initial treatment items (either the HT or CR); 
 Children’s home postcodes; 
 Clinical and radiographic findings (when radiographs were used) annually for routine 
appointments as well as for any additional non-routine (e.g. emergency) appointments. 
Teeth experiencing failed treatments and exfoliation were noted. Diagnosis and 
treatment outcomes were recorded using standard clinical outcome measures. 
Radiographs were assessed independently by two calibrated researchers.  
In order to measure time and travel costs for the present analysis, the following estimates were 
used. (1) Times for re-treatments (e.g. restorative, endodontic treatment, extractions) were 
estimated for each unit of re-treatment from another randomized trial in a similar practice-
based setting in Scotland { ADDIN EN.CITE { ADDIN EN.CITE.DATA }}, except for re-
treatment involving general anaesthesia, where we assumed – based on expert consensus – 
a total of 300 minutes to be spent overall (including preparation for surgery, anaesthesia, 
operating time, and recovery). (2) Travelling times and distances for travel to and from the 
appointment were calculated, assuming travel from home to the practice, using the postcode 
data provided by patients and practices. Times and distances were estimated using the 
Google Distance°Matrix°API, a service that calculates distances and travel times between 
locations using an HTTP request. Note that we assumed travel by car for distances above 
800 m, otherwise travel by foot was assumed. 
 
Currency, price date and discount rate 
Costs were calculated in Pound Sterling (Great British Pound, GBP) 2017. Note that the trial 
was conducted between 2001 and 2007, but using current costs increases the interpretability 
of possible cost-differences. Future costs (i.e. those experienced during follow-up) were 
discounted at 1.5% per annum { ADDIN EN.CITE 
<EndNote><Cite><Author>NICE</Author><Year>2012</Year><RecNum>19710</RecNum>
<DisplayText>(NICE 2012)</DisplayText><record><rec-number>19710</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1524641725">19710</key></foreign-keys><ref-type name="Web 
Page">12</ref-
type><contributors><authors><author>NICE,</author></authors></contributors><titles><title
>Methods for the development of NICE public health guidance (third 
edition)</title></titles><dates><year>2012</year></dates><pub-
location>https://www.nice.org.uk/process/pmg4/chapter/incorporating-health-
economics</pub-location><urls></urls></record></Cite></EndNote>}. Discounting accounts 
for the lost opportunities when spending money now instead of later.  
 
Health outcomes and effectiveness 
Our primary outcome was survival of molars, measures as proportion (in %). Our secondary 
outcomes were the proportion of molars not causing pain, or needing endodontic treatment or 
extraction and the proportion of molars not needing any kind of re-restoration.  The flow of 
participants during follow-up is shown in Figure 1. 
 
Estimation of costs 
A societal perspective was taken. Direct dental treatment costs were estimated using the NHS 
Scotland perspective in our base-case analysis. Dental treatments in Scotland for children are 
reimbursed by the NHS using a capitation and a fee per item system of the British Dental 
Association (BDA). The out-of-pocket dental expenses for pediatric patients is negligible, and 
there were unlikely to be substantial out-of-pocket expenses outside of the dental surgery. Also 
note that costs for over the counter medication are paid for by the government and 
prescriptions are provided free to the patient.  
The BDA item catalogue for Scotland 2017 was used to determine costs for the treatments 
carried out, as described in the Appendix. All costs were calculated per molar, assuming the 
split-mouth design to be an element of the trial and not reflecting typical real-life dental care. 
Note, however, that treating multiple teeth in the same mouth may affect cost-effectiveness. 
Also note that not accounting for the split-mouth design has likely reduced the statistical power 
of our analyses to some degree; we accepted these limitations. In a sensitivity analysis, an 
NHS England perspective was chosen, as described in detail in the Appendix.  
Indirect/opportunity costs were estimated based on the data available, ignoring the split-mouth 
design (assuming the patient visited for only having one molar treated by either HT or CR) as 
follows. A number of assumptions had to be made: (1) Travel costs were costs for 
transportation to and from appointments, and derived per mile travelled using the standard UK 
mileage rate for cars, 0.45 GBP/mile { ADDIN EN.CITE 
<EndNote><Cite><Author>HMRC</Author><Year>2017</Year><RecNum>19732</RecNum
><DisplayText>(HMRC 2017)</DisplayText><record><rec-number>19732</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1525270701">19732</key></foreign-keys><ref-type name="Web 
Page">12</ref-
type><contributors><authors><author>HMRC</author></authors></contributors><titles><titl
e>Travel - mileage and fuel rates and allowances 
</title></titles><dates><year>2017</year></dates><pub-
location>https://www.gov.uk/government/publications/rates-and-allowances-travel-mileage-
and-fuel-allowances/travel-mileage-and-fuel-rates-and-allowances</pub-
location><urls></urls></record></Cite></EndNote>}. If travel by foot was assumed, no 
mileage was applied. (2) Time costs measure the value of forgone alternative activities which 
could have been performed during the time spent for attending the dentist. Time costs were 
considered for parents, not the child participant { ADDIN EN.CITE { ADDIN EN.CITE.DATA }}. 
Time costs included travel time, waiting time, and time for appointments, including initial and 
re-treatment appointments. A mean gross hourly UK wage in 2017 (13.94 GBP) was applied 
to these times (the hourly wage in Scotland differs minimally, by 0.04 and 0.39 GBP for public 
and private wages, respectively) { ADDIN EN.CITE <EndNote><Cite><Author>Office for 
National 
Statistics</Author><Year>2017</Year><RecNum>19733</RecNum><DisplayText>(Office 
for National Statistics 2017; Statista 2018)</DisplayText><record><rec-number>19733</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1525272920">19733</key></foreign-keys><ref-type name="Web 
Page">12</ref-type><contributors><authors><author>Office for National 
Statistics,</author></authors></contributors><titles><title>Earnings in Scotland 
2016</title></titles><dates><year>2017</year></dates><pub-
location>http://www.parliament.scot/ResearchBriefingsAndFactsheets/S5/SB_16-
92_Earnings_in_Scotland_2016.pdf</pub-
location><urls></urls></record></Cite><Cite><Author>statista</Author><Year>2018</Year>
<RecNum>19734</RecNum><record><rec-number>19734</rec-number><foreign-
keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1525272978">19734</key></foreign-keys><ref-type name="Web 
Page">12</ref-
type><contributors><authors><author>Statista,</author></authors></contributors><titles><ti
tle>Median hourly earnings for full-time employees (excluding overtime pay and hours) in the 
United Kingdom (UK) from 2006 to 2017 (in 
GBP)</title></titles><dates><year>2018</year></dates><pub-
location>https://www.statista.com/statistics/280687/median-hourly-earnings-for-full-time-
employees-in-the-uk-since-2006/</pub-location><urls></urls></record></Cite></EndNote>}. 
We accounted for possible unemployment { ADDIN EN.CITE 
<EndNote><Cite><Author>ONS</Author><Year>2018</Year><RecNum>19736</RecNum>
<DisplayText>(ONS 2018; Scottish Government 2018)</DisplayText><record><rec-
number>19736</rec-number><foreign-keys><key app="EN" db-
id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" timestamp="1525278177">19736</key></foreign-
keys><ref-type name="Web Page">12</ref-
type><contributors><authors><author>ONS,</author></authors></contributors><titles><title
>Unemployment </title></titles><dates><year>2018</year></dates><pub-
location>https://www.ons.gov.uk/employmentandlabourmarket/peoplenotinwork/unemployme
nt</pub-location><urls></urls></record></Cite><Cite><Author>Scottish 
Government</Author><Year>2018</Year><RecNum>19735</RecNum><record><rec-
number>19735</rec-number><foreign-keys><key app="EN" db-
id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" timestamp="1525278137">19735</key></foreign-
keys><ref-type name="Web Page">12</ref-type><contributors><authors><author>Scottish 
Government,</author></authors></contributors><titles><title>Scotlands Labour Market 
Statistics</title></titles><dates><year>2018</year></dates><pub-
location>http://www.gov.scot/Topics/Statistics/Browse/Labour-Market/LMTrends</pub-
location><urls></urls></record></Cite></EndNote>}, with time not spent in work being valued 
at 5.16 GBP { ADDIN EN.CITE <EndNote><Cite><Author>Department for 
Transport</Author><Year>2015</Year><RecNum>19731</RecNum><DisplayText>(Depart
ment for Transport 2015)</DisplayText><record><rec-number>19731</rec-number><foreign-
keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1525270173">19731</key></foreign-keys><ref-type name="Web 
Page">12</ref-type><contributors><authors><author>Department for 
Transport,</author></authors></contributors><titles><title>Provision of market research for 
value of travel time savings and 
reliability</title></titles><dates><year>2015</year></dates><pub-
location>https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attach
ment_data/file/470229/vtts-phase-2-report-non-technical-summary-issue-august-
2015.pdf</pub-location><urls></urls></record></Cite></EndNote>}.  
 
Analytical methods 
Log-rank test was used to explore the level of statistical significance in survival between 
therapies. Note that for this analysis, the split-mouth design of the study was ignored. 
Bootstrapping was then performed to construct a sampling distribution of mean costs and 
effectiveness, yielding 95% confidence intervals (CI) around the mean values. Performance of 
the HT and the CRs were ranked according to their costs, and the more expensive strategy 
compared against the less expensive one using incremental-cost-effectiveness ratios (ICER). 
ICERs express the cost difference per gained or lost effectiveness; positive ICERs indicate 
additional costs per additional effectiveness, while negative ICERs indicate additional costs 
per effectiveness loss. The strategy which is less expensive and more effective dominates the 
other strategy. 
Using estimates for costs (c, in GBP) and effectiveness (e, in years), the net benefit of each 
strategy combination was calculated using the formula  
𝑛𝑒𝑡 𝑏𝑒𝑛𝑒𝑓𝑖𝑡 =  𝜆 × ∆𝑒 − ∆𝑐, 
with 𝜆 denoting the ceiling threshold of willingness to pay, i.e. the additional costs a decision 
maker is willing to bear for gaining an additional unit of effectiveness { ADDIN EN.CITE 
<EndNote><Cite><Author>Drummond</Author><Year>2005</Year><RecNum>834</RecNu
m><DisplayText>(Drummond et al. 2005)</DisplayText><record><rec-number>834</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="0">834</key></foreign-keys><ref-type name="Book">6</ref-
type><contributors><authors><author>Drummond, M</author><author>Sculpher, 
M</author><author>Torrance, G</author><author>O&apos;Brien, 
B</author><author>Stoddart, G</author></authors></contributors><titles><title>Methods for 
Economic Evaluation of Health Care 
Programmes</title></titles><number>3</number><dates><year>2005</year></dates><publi
sher>Oxford University Press</publisher><urls></urls></record></Cite></EndNote>}. If 𝜆 >
∆𝑐/∆𝑒, an alternative intervention is considered more cost-effective than the comparator 
despite possibly being more costly { ADDIN EN.CITE 
<EndNote><Cite><Author>Briggs</Author><Year>2002</Year><RecNum>935</RecNum><
DisplayText>(Briggs et al. 2002)</DisplayText><record><rec-number>935</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="0">935</key></foreign-keys><ref-type name="Journal Article">17</ref-
type><contributors><authors><author>Briggs, Andrew H.</author><author>O&apos;Brien, 
Bernie J.</author><author>Blackhouse, 
Gordon</author></authors></contributors><titles><title>Thinking outside the box: Recent 
Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness 
Studies</title><secondary-title>Annual Review of Public Health</secondary-
title></titles><pages>377-
401</pages><volume>23</volume><number>1</number><dates><year>2002</year><pub-
dates><date>2002/05/01</date></pub-dates></dates><publisher>Annual 
Reviews</publisher><isbn>0163-7525</isbn><urls><related-
urls><url>http://dx.doi.org/10.1146/annurev.publhealth.23.100901.140534</url></related-
urls></urls><electronic-resource-
num>10.1146/annurev.publhealth.23.100901.140534</electronic-resource-num><access-
date>2013/05/15</access-date></record></Cite></EndNote>}. We used the net-benefit 
approach to calculate the probability of a strategy being cost-effective for payers with different 
willingness-to-pay ceiling thresholds.  
Statistical analysis was performed using SPSS 22 (IBM, Armonk, IL, USA); bootstrapping was 
performed in Python using numpy and pandas modules. Cost-effectiveness acceptability was 
evaluated using TreeAge Pro (TreeAge, Williamstown, MA, USA) 
 
Results 
Effectiveness  
The survival curve for both strategies is shown in Figure 2, with significant differences in 
survival between strategies (p=0.007/Log-rank). Significantly more molars in HT survived (99, 
95% CI: 98-100%) than in CR (92; 87-97%). The proportion of molars retained without pain or 
requiring endodontic treatment/ extraction was also significantly higher in HT than CR (Table 
1). Teeth treated with the HT also tended to show fewer re-restorations than CR; however, this 
difference was not significant in the bootstrapped sample (Table 1). 
 
Costs 
In the base-case analysis, initial costs for HT were nearly three times as high as those for CR. 
However, including re-treatment costs, direct dental treatment costs from an NHS Scotland 
perspective found HT (24; 23-25 GBP) to not be significantly cheaper than CR (29; 17-46 
GBP). Estimating direct dental treatment costs from an NHS England perspective found HT to 
be significantly less expensive (29; 25-34 GBP) than CR (107; 86-127 GBP). 
Indirect/opportunity costs were significantly lower for HT (32, 31—34 GBP) than CR (49; 34-
69 GBP), with travel and time costs being significantly lower (Table 1). Total cumulative costs 
were significantly lower in HT (32; 31-34 GBP) than CR (49; 34-69 GBP). 
 
Cost-effectiveness 
HT dominated CRs, being less costly and more effective (Figure 3), with a mean ICER of  
-2.38 GBP spent additionally while losing 1% of molar survival when choosing CR instead of 
HT. The probability of HT being cost-effective was 87% at a willingness-to-pay threshold of 0 
GBP (Figure 4), and increased to 100% with increasing willingness-to-pay. Hence, HT had 
acceptable cost-effectiveness regardless of a payer’s willingness-to-pay. Also when 
considering the proportion of molars without pain or endodontic treatment/ extraction (ICER -
1.28 GBP/%) and the proportion of molars without any re-restorations (ICER -0.47 GBP/%), 
HT was more cost-effective than CR. 
 
Discussion 
In this day of limited resources, costs are relevant both for those paying for care and those 
commissioning it. In this study, we found HT to be significantly less costly than CR when 
considering direct dental treatment and indirect/opportunity costs. This was mainly because 
HT was clinically more successful and resulted in significantly fewer re-treatments, some of 
which are relatively expensive (e.g. treatment under general anaesthesia); these long-term 
savings compensated for the initially higher costs of providing HT. The cost-ranking holds in 
our sensitivity analysis, where direct dental treatment costs were estimated from an NHS 
England perspective. This was despite remuneration being realized very differently in England 
than Scotland,  and direct costs showing a substantially different magnitude in England (being 
much higher) than Scotland. Given that a recent study (Schwendicke et al. 2018) found HT to 
have superior cost-effectiveness under a German healthcare perspective (over a 2 years 
horizon) compared with CR and non-restorative cavity control, the cost-advantages of HT 
seem to be generalizable across settings. While this study had only assessed costs of parental 
absenteeism (for travel and time spent at the dental office), the present study added costs for 
travelling etc into the estimation.  As CR needed significantly more appointments during follow-
up, with higher travelling costs, and higher opportunity costs, than HT, we are confident that 
on multiple cost levels, HT seems advantageous. 
Using our primary outcome of molar survival, HT was significantly superior over CR. Also, HT 
required fewer re-treatments and HT molars experienced fewer episodes of pain, endodontic 
therapy and extraction; these outcomes are likely to be of high relevance for patients, but also 
providers. In summary, HT showed high cost-effectiveness, dominating CR. Based on our 
analysis, HT yields benefits for patients, providers, but also parents of the treated child from a 
number of perspectives. As HT has also demonstrated high acceptability and applicability { 
ADDIN EN.CITE { ADDIN EN.CITE.DATA }}, it may be suitable for providing effective, efficient 
and acceptable care to cavitated carious lesions in children’s primary molars.  
This study has a number of strengths and limitations. The greatest strength is that the basis of 
our analysis was a randomized, practice-based, long-term trial, which followed many of the 
treated molars until exfoliation. The trial thus allowed us to consider not only the initial or short-
term aspects of costs and effectiveness, but to capture the long-term impact of HT and CR. 
Being able to follow teeth from their initial treatment until the final event of “success” 
(exfoliation) is something which is seldom possible and rarely seen in Dentistry. The trial and 
its subsequent analyses comprehensively inform decision-makers as to the effectiveness, the 
subjective impact and the cost-effectiveness of HT and CR in a setting with high external 
validity. A further strength is that we considered not only direct dental treatment costs (from 
two perspectives), but also indirect/opportunity costs, i.e. costs resulting from direct dental 
treatment, and costs placed on the time spent for this treatment or travelling to appointments 
etc. These costs have been found relevant especially for chronic diseases { ADDIN EN.CITE 
{ ADDIN EN.CITE.DATA }}, where costs for absenteeism (e.g. time of work) or presenteeism 
(e.g. time at work during which one is limited by the disease) are substantial { ADDIN EN.CITE 
{ ADDIN EN.CITE.DATA }}. We also demonstrated the relevance of repeated travelling to and 
from dental practices, and of the time spent for these appointments on the cost-effectiveness. 
The main limitation of the study is that it is in parts retrospective in nature. We built on 
prospectively collected initial treatment times, but needed to make assumptions as to the time 
needed for re-treatment as well as on travel time and costs. Obviously, these assumptions 
may not perfectly hold true; and caution is needed when interpreting the generated data. Given 
the unambiguous ranking of HT and CR, we are confident that our findings are robust, but we 
highlight that the absolute differences may be over- or under-estimated to some degree. In 
addition, the study itself is prone to bias by design. For example, operator and also examiner 
blinding were impossible. Other aspects like attrition and selection bias can be largely excluded 
given this was a split-mouth study, where imbalanced inclusion or loss-to-follow-up is not an 
issue. Last, the latter aspect – the study being split-mouth – was ignored in our analysis, as 
we assumed the pairing of different treatments for the same condition within the same patient 
to be something artificially introduced by the trial. In daily care, dentists would probably apply 
the same therapy for similarly affected teeth in the same patient. While obviously, and as 
mentioned, the clustering of teeth within a mouth, even when treated identically, would affect 
cost-effectiveness (mainly reducing indirect and opportunity costs), our approach seemed 
justified to allow a useful comparative analysis of HT versus CR. 
A number of recommendations can be made from our study. From a research perspective, 
future trials should routinely be record efficiency data in detail, including time spent, staff and 
material needed, and details on travel (mode and distance) as well as patients’/parents’ 
occupational status (to allow assigning monetary values to times). Efficiency data should not 
only be collected for the initial, but all provided treatments (also during follow-up), as this long-
term perspective is relevant; comparing only initial costs would have led to different cost-
effectiveness rankings in our study. From a clinical perspective, our study adds another 
argument supporting HT for managing cavitated carious lesions in primary molars. Currently 
and in many healthcare systems, many cavitated primary molars are not treated at all; which 
may be grounded in parental expectations, dentists’ feeling of being unskilled in the 
management of children, and the polarization of these cavities in a few high-risk children who 
are complex to manage. HT may allow some of these barriers to be addressed, having been 
found easy to perform, acceptable for patients and parents, and also cost-effective. Extraction 
of decayed primary teeth alone, carried out under general anaesthesia, costs an estimated 
£36 million annually { ADDIN EN.CITE 
<EndNote><Cite><Author>NWPH</Author><Year>2014</Year><RecNum>19756</RecNum
><DisplayText>(NWPH 2014)</DisplayText><record><rec-number>19756</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1526198549">19756</key></foreign-keys><ref-type name="Web 
Page">12</ref-
type><contributors><authors><author>NWPH,</author></authors></contributors><titles><tit
le>NHS England. Improving dental care - a call to action. Secondary Improving dental care - 
a call to action</title></titles><dates><year>2014</year></dates><pub-
location>http://www.nwph.net/dentalhealth/reports/Report_NHS_DEP_for_England_OH_Sur
vey_12yr_ 2008-09.pdf </pub-location><urls></urls></record></Cite></EndNote>}. 
Considering the predicted funding gap expected in the NHS (£27 billion by 2029/30) and the 
associated calls for innovation, efficiency and effective treatments { ADDIN EN.CITE 
<EndNote><Cite><Author>Darzi</Author><Year>2017</Year><RecNum>19757</RecNum>
<DisplayText>(Darzi et al. 2017)</DisplayText><record><rec-number>19757</rec-
number><foreign-keys><key app="EN" db-id="p0ftrtzrz5vdt5ezpt7xfvzv00p02rzzdf2s" 
timestamp="1526198621">19757</key></foreign-keys><ref-type name="Web 
Page">12</ref-type><contributors><authors><author>Darzi, A</author><author>Quilter-
Pinner, H</author><author>Kibasi, T</author></authors></contributors><titles><title>The 
Lord Darzi Review of Health and Care: Interim 
report</title></titles><dates><year>2017</year></dates><pub-location>The Lord Darzi 
Review of Health and Care: Interim report</pub-
location><urls></urls></record></Cite></EndNote>}, our findings may eventually assist 
commissioners, clinicians and parents to make informed choices for managing carious lesions 
in primary teeth.  
In conclusion, and within the limitations of this trial, HT was more cost-effective than CR for 
managing cavitated caries lesions in primary molars. HT teeth were retained for longer and 
experienced less complication at lower costs.  
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Tables 
 
Table 1: Mean (95% CI) effectiveness and costs of different treatment strategies per tooth.  
HT Hall Technique, CR Conventional Restorative treatment. Bold: statistically significant 
differences. 
 
Parameter HT CR 
Effectiveness   
Proportion survived (%) 99 (98-100)  92 (87-97)  
Proportion without pain or endodontic/ extraction complications (%) 98 (95-100)  85 (78-91)  
Proportion without any re-restoration (%) 96 (92-100)  61 (52-100)  
Direct medical costs   
Initial costs (GBP) 22.85 (n/a) 8.75 (n/a) 
Costs for endodontic treatment/ extraction re-treatments (GBP) 0 (0-0.95)  13.22 (2.11-27.77)  
Costs for restorative re-treatments (GBP) 0 (0-1.12)  8.02 (5.97-9.12)  
Subtotal cumulative (GBP) 24.12 (23.04-25.24)  29.26 (17.11-46.42)  
Indirect/opportunity costs   
Travel costs (GBP) 5.00 (4.19-5.91) 10.29 (8.40-12.56) 
Time costs (GBP) 3.21 (2.79-3.67) 8.83 (7.14-10.86) 
Subtotal cumulative (GBP) 8.25 (7.33-9.22) 19.06 (15.87-22.63) 
Total cumulative costs (GBP) 32.26 (30.83-33.98) 48.91 (34.40-68.74) 
 
  
Figure legends 
 
Figure 1: Participant recruitment, follow up and the final dataset flow are shown. 
 
Figure 2: Survival curves for the different strategies. CR: Conventional restorations, HT Hall 
Technique. 
 Figure 3: Cost-effectiveness plane. The costs (GBP) and effectiveness (survival, in %) of the 
HT (Hall Technique) and CR (conventional restorative treatment) were plotted based on 
bootstrapped sample estimates. 
 
 
Figure 4: The cost-effectiveness acceptability curve indicates how with increasing willingness-
to-pay, the probability of cost-effectiveness of different strategies changes. HT had the highest 
probability of being cost-effectiveness regardless of a hypothecated payer’s willingness-to-pay 
threshold. 
Cost-effectiveness of the Hall Technique in a Randomized Trial 
F. Schwendicke, J. Krois, M. Robertson, C. Splieth, R. Santamaria, and N. Innes 
 
Appendix 
In the base-case, direct dental treatment costs were estimated from an NHS Scotland 
perspective. Initial and re-treatment costs were derived from fee items of NHS Scotland dental 
item fee catalogue. A range of treatment fee items are used for different initial and re-
treatments, as indicated in the Appendix Table. For HT, the placement of a stainless steel 
crown was charged. For CRs, a direct restoration (filling) was charged. Re-treatments involved 
re-cementation or new placement of stainless steel crowns, pulpotomy or extraction in 
combination with local anesthesia or under general anesthesia.  
  
Appendix Table: Cost estimation. Costs were derived using the BDA Scotland fees guide. 
Items were charged as part of different initial treatments (HT Hall Technique, CR Conventional 
restorative treatment), and also when they occurred as re-treatment items (retreat). 
Treatment Item GBP Charged  
Direct restoration 4401 8.75 CR 
Hall Crown 4402 22.85 HT 
Pulpotomy 4403 9.15 Retreat 
Stainless steel crown 4402 22.85 Retreat 
Re-cementation 1782 11.70 Retreat 
Extraction 2102 8.75 Retreat 
Antibiotics4 3701 8.45 + 1.29* Retreat 
General anesthesia 
(fixed value)  
- 
719.90** 
 
Retreat 
* mean pharmaceutical costs for standard antibiotics, NHS National Services Scotland. 
www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Scottish-Drug-Tariff/Drugs-and-Preparations-with-
Tariff-Prices.asp  
** { HYPERLINK "http://www.scottishdental.org/wp-content/uploads/2017/03/SDNAP_Oral-
Health-Dental-Services-for-Children-2017.pdf" } 
  
In the sensitivity analysis, direct medical costs were estimated within the NHS England 
perspective. Under this system, treatments are charged within Bands; these Bands cover all 
treatments falling into it together with any possible treatments in lower Bands regardless of 
their quantity (placing one filling is paid the same as placing five) as long as they occur during 
the same course of treatment. Band 1 includes assessment and advice, radiographs etc., Band 
2 includes direct restorations including stainless steel/Hall crowns and endodontic treatments 
(pulp therapies); Band 3 includes lab work. There are additional Bands for urgent treatments 
(mainly for pain alleviation) and prescriptions. To reflect the different efforts within the Bands, 
each Band comes with a different number of Unit of Dental Activities (UDAs) being charged 
(1, 3 and 12 UDAs for Band 1, 2 and 3, respectively). The mean UDA value paid within the 
NHS England in 2016/17 was 31.63 GBP. Hence, for example, for placing a Hall crown, falling 
under Band 2, 3 UDAs worth a total of 94.89 GBP would be claimed; this would cover any 
further direct restorations or assessments etc. needed. Hence, any tooth-based estimations 
ignoring possible treatments on further teeth may come with distortions, we accepted that. We 
assumed (in the absence of having claims data for NHS England, given the setting of the trial) 
the courses of treatment to be completed within two months; i.e. re-interventions in the same 
or lower Band were charged again once they were provided more than two months after the 
previous treatment (in line with NHS regulations, treatments within higher Bands were claimed 
regardless, as these are not covered by a lower Band treatment). Note that this regulation did 
not apply when the last treatment was an urgent treatment/prescription (as a separate course 
of treatment is commenced after any urgent treatment has been provided). For GA, children 
usually received multiple extractions and costs were assumed to be generated accordingly ({ 
HYPERLINK "https://www.nice.org.uk/guidance/ph55/resources/costing-statement-pdf-
69284125" }) at 558 GBP. Note, however, that we again did not distribute these costs among 
teeth as we did not know the exact number of removed teeth. 
 
